ILMN:NASDAQ
Illumina Inc
$225.94
arrow_upward
+8.52%(+17.73) 1D
Sep 15, 2:11:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ILMN...
Open
$208.95
High
$226.30
Low
$207.90
Mkt. cap
34.09B
Avg. vol.
1.90M
Volume
1.64M
P/E ratio
42.00
52-wk high
$231.81
52-wk low
$88.00
EPS
$5.38
Beta
1.46
Shares outstanding
151.00M
No. of employees
9K
Open
$208.95
High
$226.30
Low
$207.90
Mkt. cap
34.09B
Avg. vol.
1.90M
Volume
1.64M
P/E ratio
42.00
52-wk high
$231.81
52-wk low
$88.00
EPS
$5.38
Beta
1.46
Shares outstanding
151.00M
No. of employees
9K
News stories
From web sources and news partners
Investing.com
·
5 minutes ago
Crowdstrike and Illumina among market cap stock movers on Tuesday
Benzinga
·
46 minutes ago
10-Year Yield Tops 5%, Oil Storms Past $105: Stock Market Today
StocksToTrade
·
1 hour ago
Illumina Stock Climbs As Analyst Upgrades Meet S&P 500 Boost
Timothy Sykes
·
1 hour ago
Illumina (ILMN) Stock Draws Bullish Targets As S&P 500 Inclusion Nears
Profile
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Wikipedia
About Illumina Inc
CEOJacob Thaysen
Employees8.62K
Founded1998
HeadquartersSan Diego, California, United States
SectorHealth care
Websiteillumina.com